Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C33H57N11O9.2C2H4O2 |
Molecular Weight | 871.9779 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)=O.CC(O)=O.C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2CCC[C@H]2C(=O)NCC(=O)N3CCC[C@H]3C(O)=O
InChI
InChIKey=VHEHIIUPYDNNTE-UXAXJNOXSA-N
InChI=1S/C33H57N11O9.2C2H4O2/c1-19(45)26(35)29(49)41-20(8-2-3-13-34)30(50)44-17-6-11-23(44)28(48)40-21(9-4-14-38-33(36)37)31(51)43-16-5-10-22(43)27(47)39-18-25(46)42-15-7-12-24(42)32(52)53;2*1-2(3)4/h19-24,26,45H,2-18,34-35H2,1H3,(H,39,47)(H,40,48)(H,41,49)(H,52,53)(H4,36,37,38);2*1H3,(H,3,4)/t19-,20+,21+,22+,23+,24+,26+;;/m1../s1
Molecular Formula | C2H4O2 |
Molecular Weight | 60.052 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C33H57N11O9 |
Molecular Weight | 751.874 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. | 2001 May-Jun |
|
Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions. | 2002 Feb |
|
[Selank and short peptides of Taftsin derivatives in regulation of adaptive behavior of animals in stress]. | 2002 Jun |
|
[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. | 2008 |
|
[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. | 2008 |
|
Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. | 2008 Jul-Aug |
|
[Compensatory effect of selank on the mnestic functions disturbed by neurotoxic damage of the noradrenergic system of the rat brain]. | 2008 Mar-Apr |
|
[Compensatory and antiamnestic effects of heptapeptide Selank in monkeys]. | 2008 May-Jun |
|
[Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study]. | 2008 Sep-Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:53:22 GMT 2023
by
admin
on
Sat Dec 16 14:53:22 GMT 2023
|
Record UNII |
Q94Z9E92UU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
155804769
Created by
admin on Sat Dec 16 14:53:22 GMT 2023 , Edited by admin on Sat Dec 16 14:53:22 GMT 2023
|
PRIMARY | PUBCHEM | ||
|
Q94Z9E92UU
Created by
admin on Sat Dec 16 14:53:22 GMT 2023 , Edited by admin on Sat Dec 16 14:53:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |